The Weekly Litigation News Digest is now live. Subscribe now

Teoxane competitive analysis

Loading summary...

Explore Teoxane's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Oct 30, 2024Process For Preparing A Crosslinked Gel1
Jan 26, 2022Injection Devices Comprising A Composition Of Hyaluronic Acid And Mepivacaine Hydrochloride1
Dec 22, 2021Dermal Injectable Sterile Composition1
Jun 2, 2021Process Of Preparing A Cross Linked Gel2
Nov 6, 2019Process For Preparing Hydrogels2
Oct 2, 2019Process For Evaluating The Mechanical Performance Of A Filler Gel1
Jun 19, 2019Composition Comprising Hyaluronic Acid And Mepivacaine3

Latest PTAB cases involving Teoxane

Discover the latest PTAB cases involving Teoxane, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Teoxane

IPR2017-02002Aug 24, 2017TEOXANEALLERGANInstitution Denied
IPR2017-01906Aug 2, 2017TEOXANEALLERGANInstitution Denied

Peer Comparison New

IP litigation analysis comparing Teoxane with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TEOXANE - 112 -
ALLERGAN11291333
LABORATOIRES VIVACY11 - - -
MERZ PHARMA176 - -